Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04632342
What this trial is testing

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Who this might be right for
Radiation PneumonitisLung Cancer
Hanlim Pharm. Co., Ltd. 87
Not applicableUnknownNCT03093727
What this trial is testing

Characterization of Pulmonary Langerhans Cell Histiocytosis

Who this might be right for
Langerhans Cell Histiocytoses
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 20
Not applicableStudy completedNCT06539962
What this trial is testing

Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease

Who this might be right for
Interstitial Lung DiseaseCardiovascular Morbidity
Assiut University 134
Large-scale testing (Phase 3)Study completedNCT01862926
What this trial is testing

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more
Royal Brompton & Harefield NHS Foundation Trust 104
Testing effectiveness (Phase 2)WithdrawnNCT04677426
What this trial is testing

129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study

Who this might be right for
Idiopathic Pulmonary FibrosisHypersensitivity Pneumonitis
University of Kansas Medical Center
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT07712952
What this trial is testing

Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal Study

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
Chung-Ang University Hospital 175
Large-scale testing (Phase 3)Study completedNCT03820726
What this trial is testing

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 435
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableUnknownNCT03238989
What this trial is testing

Interstitial Lung Disease Registry Construction

Who this might be right for
Interstitial Lung Disease
Seoul National University Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT06940427
What this trial is testing

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Who this might be right for
Fibrosis Lung
University of Wisconsin, Madison 50
Early research (Phase 1)Study completedNCT02625246
What this trial is testing

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Bronchiectasis
Marilyn Glassberg 6
Not applicableUnknownNCT04428957
What this trial is testing

Telemonitoring of Treatment Effects in Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD)

Who this might be right for
Connective Tissue Disease-associated Interstitial Lung DiseaseInterstitial Lung DiseaseConnective Tissue Diseases
Medical University of Lodz 60
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Not applicableUnknownNCT04952675
What this trial is testing

Evaluation of Pneumoconiosis High Risk Early Warning Models

Who this might be right for
Pneumoconiosis
Peking University Third Hospital 200
Early research (Phase 1)Study completedNCT06939504
What this trial is testing

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599111
What this trial is testing

Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Who this might be right for
Pneumonitis, InterstitialImmune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells+1 more
Zhou Chengzhi 40
Testing effectiveness (Phase 2)Study completedNCT01214187
What this trial is testing

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Brigham and Women's Hospital 58
Not applicableStudy completedNCT03140644
What this trial is testing

SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Rennes University Hospital 196
Not applicableUnknownNCT05345795
What this trial is testing

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 600
Next Page